Immediate Impact
1 by Nobel laureates 3 from Science/Nature 53 standout
Citing Papers
Principles and therapeutic applications of adaptive immunity
2024 Standout
Nanomedicine Tumor Targeting
2024 Standout
Works of Nancy S. Scher being referenced
First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer
2013
End points to establish the efficacy of new agents in the treatment of acute leukemia
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nancy S. Scher | 270 | 123 | 13 | 94 | 8 | 407 | |
| S. Jagdev | 393 | 185 | 6 | 72 | 8 | 456 | |
| Jose Cruz | 310 | 49 | 4 | 147 | 11 | 412 | |
| C Weiler | 187 | 90 | 24 | 133 | 8 | 418 | |
| Francesco Bertoldo | 224 | 89 | 107 | 13 | 379 | ||
| Jeannette Soria | 157 | 65 | 1 | 91 | 11 | 410 | |
| Céline Le Gall | 333 | 143 | 1 | 146 | 6 | 440 | |
| Sarah Morgan | 231 | 46 | 2 | 149 | 12 | 416 | |
| Kevin Forsythe | 76 | 27 | 1 | 55 | 13 | 416 | |
| R. Blanco | 271 | 15 | 17 | 46 | 11 | 448 | |
| Julia K. L. Woodward | 227 | 77 | 2 | 184 | 13 | 403 |
All Works
Loading papers...